#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Non-small cell lung cancer metastatic Type 2 diabetes mellitus More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Duchenne muscular dystrophy gene carrier Extraskeletal ossification Anti-myelin-associated glycoprotein antibodies positive Neuroendocrine tumour Von Willebrand's disease Medullary thyroid cancer Infertility male Squamous cell carcinoma of the cervix Retinopathy proliferative Sarcoma Osteomyelitis Pyruvate dehydrogenase complex deficiency Ovarian epithelial cancer Growth hormone deficiency Adenoid cystic carcinoma More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease – Trials in Disease Mucopolysaccharidosis III – Treatment Medulloblastoma – Diagnostics Bronchiolitis obliterans syndrome Acquired haemophilia Pleural mesothelioma malignant – Trials in Disease Hereditary angioedema – Life with Disease Marginal zone lymphoma – Trials in Disease Small intestine leiomyosarcoma – Basic Information Mucopolysaccharidosis I More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    [18F]DED Ecoo18A Ngm707 Naloxone Hydrochloride MARALIXIBAT Cart45Ra-Nkg2D Cells Agrostis Stolonifera Pollen STREPTOCOCCUS VIRIDANS Sodium Acetate (1-13C) Rmc-035 Estradiol 11902A Quinapril Hydrochloride Isis 696844 Vortioxetine Nirogacestat Hydrobromide HUMAN PLASMA Collagenase Canis Familiaris (553) Peboctocogene Camaparvovec More therapies…

    Learn about Your Condition

    Weaning failure Complex regional pain syndrome Vomiting Glaucoma Stress cardiomyopathy Toxic epidermal necrolysis Hyperchylomicronaemia Plasma cell leukaemia Malignant glioma Polymyalgia rheumatica Sinus rhythm Medulloblastoma recurrent Migraine without aura Muscle hypertrophy Yellow fever More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Elisabeth-TweeSteden Ziekenhuis

Elisabeth-TweeSteden Ziekenhuis

Henyttrrzidlbm Wmd 6qp Txcjxctf 5rotu Noryojcecsx

Want to learn more about this study or check if you can participate? Contact us.

  • Discontinuation of methotrexate (drug combination) in rheumatoid arthritis patients using TNF inhibitors

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Methotrexate Disodium
    • Golimumab
    • Adalimumab
    The Netherlands

  • Study on Oral Antibiotics Moxifloxacin, Linezolid, and Metronidazole for Patients with Bacterial Brain Abscess

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Brain abscess
    Investigated Drugs:
    • Meropenem Anhydrous
    • Moxifloxacin Hydrochloride
    • Ceftriaxone Sodium
    Denmark France The Netherlands Sweden

  • Study on Personalized Dosing of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Natalizumab
    The Netherlands

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!